Ubs Group Ag Karuna Therapeutics, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$161.01 - $317.85 $67.5 Million - $133 Million
419,217 Added 14157.95%
422,178 $134 Million
Q3 2023

Nov 09, 2023
SELL
$164.66 - $218.08 $2.23 Million - $2.96 Million
-13,555 Reduced 82.07%
2,961 $500,000
Q2 2023

Aug 11, 2023
SELL
$176.32 - $240.22 $1.54 Million - $2.1 Million
-8,750 Reduced 34.63%
16,516 $3.58 Million
Q1 2023

May 12, 2023
BUY
$161.33 - $204.36 $143,422 - $181,676
889 Added 3.65%
25,266 $4.59 Million
Q4 2022

Feb 08, 2023
BUY
$191.53 - $236.82 $3.96 Million - $4.9 Million
20,672 Added 557.95%
24,377 $4.79 Million
Q3 2022

Nov 10, 2022
SELL
$123.79 - $277.42 $771,706 - $1.73 Million
-6,234 Reduced 62.72%
3,705 $833,000
Q2 2022

Aug 10, 2022
SELL
$93.97 - $143.33 $1.89 Million - $2.88 Million
-20,061 Reduced 66.87%
9,939 $1.26 Million
Q1 2022

May 16, 2022
BUY
$98.9 - $132.37 $2.79 Million - $3.74 Million
28,242 Added 1606.48%
30,000 $3.8 Million
Q4 2021

Feb 14, 2022
SELL
$110.64 - $159.4 $2.43 Million - $3.5 Million
-21,949 Reduced 92.58%
1,758 $230,000
Q3 2021

Nov 15, 2021
BUY
$101.2 - $125.87 $2.34 Million - $2.91 Million
23,096 Added 3780.03%
23,707 $2.9 Million
Q2 2021

Aug 13, 2021
SELL
$107.45 - $135.95 $470,416 - $595,189
-4,378 Reduced 87.75%
611 $70,000
Q1 2021

May 12, 2021
BUY
$95.46 - $133.08 $409,046 - $570,247
4,285 Added 608.66%
4,989 $600,000
Q4 2020

Feb 11, 2021
SELL
$75.23 - $109.23 $5,717 - $8,301
-76 Reduced 9.74%
704 $72,000
Q3 2020

Nov 12, 2020
SELL
$71.31 - $109.74 $117,233 - $180,412
-1,644 Reduced 67.82%
780 $61,000
Q2 2020

Jul 31, 2020
BUY
$62.14 - $117.21 $22,743 - $42,898
366 Added 17.78%
2,424 $271,000
Q1 2020

May 01, 2020
SELL
$60.41 - $115.92 $54,610 - $104,791
-904 Reduced 30.52%
2,058 $149,000
Q4 2019

Feb 14, 2020
SELL
$11.44 - $123.99 $6,131 - $66,458
-536 Reduced 15.32%
2,962 $223,000
Q3 2019

Nov 14, 2019
BUY
$16.05 - $27.35 $56,142 - $95,670
3,498 New
3,498 $57,000

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email